Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
T cell homeostatic proliferation elicits effective antitumor autoimmunity
Wolfgang Dummer, … , Ralph A. Reisfeld, Argyrios N. Theofilopoulos
Wolfgang Dummer, … , Ralph A. Reisfeld, Argyrios N. Theofilopoulos
Published July 15, 2002
Citation Information: J Clin Invest. 2002;110(2):185-192. https://doi.org/10.1172/JCI15175.
View: Text | PDF
Article Aging

T cell homeostatic proliferation elicits effective antitumor autoimmunity

  • Text
  • PDF
Abstract

Research Article

Authors

Wolfgang Dummer, Andreas G. Niethammer, Roberto Baccala, Brian R. Lawson, Norbert Wagner, Ralph A. Reisfeld, Argyrios N. Theofilopoulos

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Inhibition of melanoma growth by homeostatic T cell proliferation. (a) N...
Inhibition of melanoma growth by homeostatic T cell proliferation. (a) Nonirradiated (circles) or sublethally irradiated (squares) C57BL/6 mice were challenged subcutaneously with 5 × 105 B78D14 melanoma cells. Groups of irradiated mice were transfused with 5 × 106 (inverted triangles) or 5 × 107 (triangles) syngeneic B6.PL LN cells. Means and standard deviation of tumor growth are indicated (all groups, n = 7). (b) Proliferation profiles of gated Thy1.1+CD4+ and Thy1.1+CD4– (CD8+) cells in secondary lymphoid organs shown as CFSE histograms. Upper panel: nonirradiated C57BL/6 mice (Thy1.2+) transfused with 107 B6.PL (Thy1.1+) cells; middle panel: C57BL/6 mice irradiated and transfused with 5 × 106 B6.PL LN cells; lower panel: C57BL/6 mice irradiated and transfused with 5 × 107 B6.PL LN cells. FACS dot plots of host lymphoid organs are depicted to the right. (c) Total number of proliferating (one or more cell divisions) donor CD4+ and CD8+ cells in C57BL/6 recipients of 5 × 106 or 5 × 107 B6.PL LN cells calculated from data presented in b.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts